A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression

Biological Psychiatry

Volumn 79, Issue 12, 2016, Pages 980-987

  Erickson, Molly A ^a   Ruffle, Abigail ^a   Gold, James M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; High risk; Meta analysis; Mismatch negativity; Prodromal; Schizophrenia

Indexed keywords

ARTICLE; ATTENTION; BIPOLAR DISORDER; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; FIRST-DEGREE RELATIVE; GENETIC RISK; HIGH RISK POPULATION; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; META ANALYSIS (TOPIC); MISMATCH NEGATIVITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SYSTEMATIC REVIEW; ADULT; EVOKED RESPONSE; FEMALE; MALE; META ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; DISEASE PROGRESSION; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84946212713     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.08.025     Document Type: Article

References (39)

1. 1 Naatanen, R., Paavilainen, P., Rinne, T., Alho, K., The mismatch negativity (MMN) in basic research of central auditory processing: A review. Clin Neurophysiol 118 (2007), 2544–2590.
2. 2 Light, G.A., Swerdlow, N.R., Rissling, A.J., Radant, A., Sugar, C.A., Sprock, J., et al. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PloS One, 7, 2012, e39434.
3. 3 Rasser, P.E., Schall, U., Todd, J., Michie, P.T., Ward, P.B., Johnston, P., et al. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull 37 (2011), 131–140.
4. 4 Takahashi, H., Rissling, A.J., Pascual-Marqui, R., Kirihara, K., Pela, M., Sprock, J., et al. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses. Neuroimage 66 (2013), 594–603.
5. 5 Rissling, A.J., Miyakoshi, M., Sugar, C.A., Braff, D.L., Makeig, S., Light, G.A., Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage Clin 6 (2014), 424–437.
6. 6 Umbricht, D., Koller, R., Vollenweider, F.X., Schmid, L., Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51 (2002), 400–406.
7. 7 Naatanen, R., Shiga, T., Asano, S., Yabe, H., Mismatch negativity (MMN) deficiency: A break-through biomarker in predicting psychosis onset. Int J Psychophysiol 95 (2015), 338–344.
8. 8 Perez, V.B., Woods, S.W., Roach, B.J., Ford, J.M., McGlashan, T.H., Srihari, V.H., Mathalon, D.H., Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: Forecasting psychosis risk with mismatch negativity. Biol Psychiatry 75 (2014), 459–469.
9. 9 Light, G.A., Naatanen, R., Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders. Proc Natl Acad Sci U S A 110 (2013), 15175–15176.
10. 10 Salisbury, D.F., Kuroki, N., Kasai, K., Shenton, M.E., McCarley, R.W., Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 64 (2007), 521–529.
11. 11 Salisbury, D.F., Shenton, M.E., Griggs, C.B., Bonner-Jackson, A., McCarley, R.W., Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Arch Gen Psychiatry 59 (2002), 686–694.
12. 12 Umbricht, D., Krljes, S., Mismatch negativity in schizophrenia: A meta-analysis. Schizophr Res 76 (2005), 1–23.
13. 13 Pol, H.E.H., Kahn, R.S., What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 34 (2008), 354–366.
14. 14 Kiang, M., Braff, D.L., Sprock, J., Light, G.A., The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clin Neurophysiol 120 (2009), 1949–1957.
15. 15 Light, G.A., Swerdlow, N.R., Thomas, M.L., Calkins, M.E., Green, M.F., Greenwood, T.A., et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res 163 (2015), 63–72.
16. 16 Bodatsch, M., Ruhrmann, S., Wagner, M., Muller, R., Schultze-Lutter, F., Frommann, I., et al. Prediction of psychosis by mismatch negativity. Biol Psychiatry 69 (2011), 959–966.
17. 17 Shaikh, M., Valmaggia, L., Broome, M.R., Dutt, A., Lappin, J., Day, F., et al. Reduced mismatch negativity predates the onset of psychosis. Schizophr Res 134 (2012), 42–48.
18. 18 Jessen, F., Fries, T., Kucharski, C., Nishimura, T., Hoenig, K., Maier, W., et al. Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia. Neurosci Lett 309 (2001), 185–188.
19. 19 Chitty, K.M., Lagopoulos, J., Lee, R.S., Hickie, I.B., Hermens, D.F., A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder. Eur Neuropsychopharmacol 23 (2013), 1348–1363.
20. 20 Bora, E., Pantelis, C., Meta-analysis of cognitive impairment in first-episode bipolar disorder: Comparison with first-episode schizophrenia and healthy controls. Schizophr Bull 41 (2015), 1095–1104.
21. 21 Leitman, D.I., Sehatpour, P., Higgins, B.A., Foxe, J.J., Silipo, G., Javitt, D.C., Sensory deficits and distributed hierarchical dysfunction in schizophrenia. Am J Psychiatry 167 (2010), 818–827.
22. 22 Javitt, D.C., Grochowski, S., Shelley, A.M., Ritter, W., Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalogr Clin Neurophysiol 108 (1998), 143–153.
23. 23 Todd, J., Harms, L., Schall, U., Michie, P.T., Mismatch negativity: Translating the potential. Front Psychiatry, 4, 2013, 171.
24. 24 Todd, J., Whitson, L., Smith, E., Michie, P.T., Schall, U., Ward, P.B., What's intact and what's not within the mismatch negativity system in schizophrenia. Psychophysiology 51 (2014), 337–347.
25. 25 Todd, J., Michie, P.T., Jablensky, A.V., Do loudness cues contribute to duration mismatch negativity reduction in schizophrenia?. Neuroreport 12 (2001), 4069–4073.
26. 26 Borenstein, M., Hedges, L., Higgins, J., Rothstein, H., Comprehensive Meta-Analysis Version 2. 2005, Biostat, Engelwood, NJ.
27. 27 Hedges, L.V., Olkin, I., Statistical Methods for Meta-Analysis. 1985, Academic Press, Orlando, FL.
28. 28 Rosenthal, R., The “file drawer problem” and tolerance for null results. Psychol Bull 85 (1979), 638–641.
29. 29 Duval, S., Tweedie, R., Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000), 455–463.
30. 30 Higuchi, Y., Seo, T., Miyanishi, T., Kawasaki, Y., Suzuki, M., Sumiyoshi, T., Mismatch negativity and p3a/reorienting complex in subjects with schizophrenia or at-risk mental state. Front Behav Neurosci, 8, 2014, 172.
31. 31 Hsieh, M.H., Shan, J.C., Huang, W.L., Cheng, W.C., Chiu, M.J., Jaw, F.S., et al. Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis. Schizophr Res 140 (2012), 243–249.
32. 32 Alain, C., Cortese, F., Bernstein, L.J., He, Y., Zipursky, R.B., Auditory feature conjunction in patients with schizophrenia. Schizophr Res 49 (2001), 179–191.
33. 33 Ford, J.M., Roach, B.J., Miller, R.M., Duncan, C.C., Hoffman, R.E., Mathalon, D.H., When it's time for a change: Failures to track context in schizophrenia. Int J Psychophysiol 78 (2010), 3–13.
34. 34 Kasai, K., Okazawa, K., Nakagome, K., Hiramatsu, K., Hata, A., Fukuda, M., et al. Mismatch negativity and N2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: A topographic event-related potential study. Schizophr Res 35 (1999), 141–156.
35. 35 Kirino, E., Inoue, R., The relationship of mismatch negativity to quantitative EEG and morphological findings in schizophrenia. J Psychiatr Res 33 (1999), 445–456.
36. 36 Kirino, E., Mismatch negativity correlates with delta and theta EEG power in schizophrenia. Int J Neurosci 117 (2007), 1257–1279.
37. 37 Lavoie, S., Murray, M.M., Deppen, P., Knyazeva, M.G., Berk, M., Boulat, O., et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33 (2008), 2187–2199.
38. 38 Horton, J., Millar, A., Labelle, A., Knott, V.J., MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients. Schizophr Res 126 (2011), 202–211.
39. 39 Shelley, A.M., Silipo, G., Javitt, D.C., Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: Implications for theories of cortical dysfunction. Schizophr Res 37 (1999), 65–79.